| Price | 1,956.00p on 19-03-2026 at 19:40:06 |
|---|---|
| Change | -16.50p -0.84% |
| Buy | 1,952.00p |
| Sell | 1,951.50p |
| Last Trade: | Buy 328.00 at 1,956.00p |
| Day's Volume: | 7,174,578 |
| Last Close: | 1,956.00p |
| Open: | 1,951.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,943.50p - 1,976.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £78.32b |
| VWAP: | 1,955.03151p |
| Shares in Issue: | 4.00b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 328 | 1,956.00p | SI Trade Negotiated Trade |
16:48:29 - 19-Mar-26 |
| Buy* | 988 | 1,956.00p | Suspected BUY Trade |
16:39:06 - 19-Mar-26 |
| Buy* | 186 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 5,005 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 45 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 140 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 273 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 470 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 473 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
| Buy* | 472 | 1,956.00p | SI Trade |
16:35:00 - 19-Mar-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Mar 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 18th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Mar 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 17th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 13th Mar 2026 10:31 am | RNS | US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 10:31 am | RNS | US FDA approves Arexvy for adults 18-49 AIR |
| 13th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
